Company: SNWV
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-014141
Chunk: 94

Company: SANUWAVE Health, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 8
Chunk 94
---
 of the Company's common stock effected on October 18, 2024.

The accompanying notes to consolidated financial statements are an integral part of these financial statements.

F-4

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(In thousands, except share data)

Common Stock   Number of Shares Issued and OutstandingPar ValueAdditional Paid-in Capital Accumulated Deficit Accumulated OtherComprehensiveLoss Total Balances as of December 31, 20221,463,300$1 $153,298 $(194,242)$(67)$(41,010)Shares issued for services34,4001 526 - - 527 Shares issued for settlement of debt1,543,7921 23,155 - - 23,156 Foreign currency translation adjustment-- - - (44)(44)Net loss-- - (25,807)- (25,807)Balances as of December 31, 20233,041,492$3 $176,979 $(220,049)$(111)$(43,178)Sale of common stock1,248,4891 10,299 - - 10,300 Shares issued for settlement of warrants3,558,3964 41,380 - - 41,384 Shares issued for settlement of debt685,7371 8,513 - - 8,514 Stock-based compensation9,572- 1,514 - - 1,514 Foreign currency translation adjustment-- - - 121 121 Net loss-- - (31,372)- (31,372)Balance as of December 31, 20248,543,686$9 $238,685 $(251,421)$10 $(12,717)

* Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares of the Company's common stock effected on October 18, 2024.

The accompanying notes to consolidated financial statements are an integral part of these financial statements.

F-5

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31, 2024 and 2023

(In thousands) 20242023